Inactivation of Wild-Type p53 by Asparagine Endopeptidase in Glioblastoma: An Opportunity to Target the "Undruggable"

被引：2
|
作者：
Manfredi, James J. [1 ,2 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2020年 / 112卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1093/jnci/djz156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：327 / 329
页数：3
相关论文
共 50 条
  • [21] Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators
    Roemer, K
    BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 879 - 887
  • [22] Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
    Szybka, M.
    Zawlik, I.
    Kulczycka, D.
    Golanska, E.
    Jesien, E.
    Kupnicka, D.
    Stawski, R.
    Piaskowski, S.
    Bieniek, E.
    Zakrzewska, M.
    Kordek, R.
    Liberski, P. P.
    Rieske, P.
    BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1431 - 1433
  • [23] An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53
    Blaszczyk-Thurin, M
    O, I
    Ertl, HCJ
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 56 (04) : 361 - 375
  • [24] EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma
    Ding, Jie
    Li, Xiaolong
    Khan, Sabbir
    Zhang, Chen
    Gao, Feng
    Sen, Shayak
    Wasylishen, Amanda R.
    Zhao, Yang
    Lozano, Guillermina
    Koul, Dimpy
    Alfred Yung, W. K.
    NEURO-ONCOLOGY, 2022, 24 (10) : 1712 - 1725
  • [25] Pharmacological activation of wild-type p53 in the therapy of leukemia
    Kojima, Kensuke
    Ishizawa, Jo
    Andreeff, Michael
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : 791 - 798
  • [26] WILD-TYPE P53 IN CELLULAR-TRANSFORMATION - A REASSESSMENT
    KOLZAU, T
    DEPPERT, W
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 3 (01) : 23 - 27
  • [27] Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation
    Lopez, Carlos A.
    Feng, Felix Y.
    Herman, Joseph M.
    Nyati, Mukesh K.
    Lawrence, Theodore S.
    Liungman, Mats
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (01): : 214 - 220
  • [28] Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function
    Dorigo, O
    Turla, ST
    Lebedeva, S
    Gjerset, RA
    JOURNAL OF NEUROSURGERY, 1998, 88 (03) : 535 - 540
  • [29] EP300 as an epigenetic target in p53 wild-type tumors treated with cisplatin
    Robaszkiewicz, A.
    Gronkowska, K.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1395 - S1395
  • [30] ACCUMULATION OF WILD-TYPE P53 PROTEIN IN HUMAN ASTROCYTOMAS
    RUBIO, MP
    VONDEIMLING, A
    YANDELL, DW
    WIESTLER, OD
    GUSELLA, JF
    LOUIS, DN
    CANCER RESEARCH, 1993, 53 (15) : 3465 - 3467
12345